ConductScience.org, home

Gene · 5873

Papers3,592

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

221 to 240 of 3,592

Download this page as JSON
TitleJournalYearPMIDFound bySource
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.Cell Transplant202438183241PubTator, text miningPubMed
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy.Cancer Cell Int202438178183PubTator, text miningPubMed
Trophoblast-derived miR-410-5p induces M2 macrophage polarization and mediates immunotolerance at the fetal-maternal interface by targeting the STAT1 signaling pathway.J Transl Med202438178171PubTator, text miningPubMed
Small RNA-big impact: exosomal miRNAs in mitochondrial dysfunction in various diseases.RNA Biol202438174992PubTator, text miningPubMed
Leafhopper salivary vitellogenin mediates virus transmission to plant phloem.Nat Commun202438167823PubTator, text miningPubMed
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity.Int J Biol Sci202438164177PubTator, text miningPubMed
Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport.J Ethnopharmacol202438158096PubTator, text miningPubMed
CD36 regulates factor VIII secretion from liver endothelial cells.Blood Adv202438157226PubTator, text miningPubMed
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance.
J Antimicrob Chemother202438153241PubTator, text miningPubMed
Bioinformatics analyses and experimental validation of the role of phagocytosis in low-grade glioma.Environ Toxicol202438112449PubTator, text miningPubMed
Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD-L1 in Cancer Therapy.Adv Sci (Weinh)202437934012PubTator, text miningPubMed
Anti-melanogenic effect of exosomes derived from human dermal fibroblasts (BJ-5ta-Ex) in C57BL/6 mice and B16F10 melanoma cells.Pigment Cell Melanoma Res202437758515PubTator, text miningPubMed
Resveratrol Inhibits Hepatocellular Carcinoma Progression through Regulating Exosome Secretion.Curr Med Chem202437711128PubTator, text miningPubMed
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants.J Allergy Clin Immunol202437678575PubTator, text miningPubMed
Advances in the engineering of the outer blood-retina barrier: From in-vitro modelling to cellular therapy.Bioact Mater202437637086PubTator, text miningPubMed
The link between intracellular calcium signaling and exosomal PD-L1 in cancer progression and immunotherapy.Genes Dis202437588227PubTator, text miningPubMed
External stimulation induces the secretion of autophagosome-like vesicles by B cells.Autophagy Rep202340395311PubTator, text miningPubMed
Four distinct cytoplasmic structures generate and release specific vesicles, thus opening the way to intercellular communication.Extracell Vesicles Circ Nucl Acids202339698300PubTator, text miningPubMed
Trafficking of hormones and trophic factors to secretory and extracellular vesicles: a historical perspective and new hypothesis.Extracell Vesicles Circ Nucl Acids202338435713PubTator, text miningPubMed
Extracellular vesicles - on the cusp of a new language in the biological sciences.Extracell Vesicles Circ Nucl Acids202338288044PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5873/papers?page=12